$SMCI Hits Nine-Day Losing Streak, RSI Below 30; Most Oversold Since April 2022, Analysts Eye $740-$750 Range

$SMCI has experienced a significant decline, marking nine consecutive days of losses, with its Relative Strength Index (RSI) dropping below 30, indicating it is the most oversold since April 2022. Analysts and traders are observing potential signs of a rebound, with some targeting a price range of $740 to $750. Recent activity suggests that the stock may be approaching its 200-day moving average, and there is a growing sentiment among traders that it could be poised for a turnaround.